CEO
Numab Therapeutics AG
Zuerich, Zurich
David Urech serves as CEO at Numab Therapeutics AG. Numab Therapeutics AG operates in the research sector with approximately 69.0 employees. The company is headquartered in Zuerich, Zurich. Numab Therapeutics AG generates annual revenue of 16599000.0. To date, Numab Therapeutics AG has raised 227259815.0 in total funding, with the most recent round being Series C.
Executives like David Urech in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Numab Therapeutics AG.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
David Urech's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Numab Therapeutics AG. Access direct contact info to skip gatekeepers and reach the decision maker.
David Urech is CEO at Numab Therapeutics AG, a company in the research sector with 69.0 employees. The company is based in Zuerich, Zurich.
As CEO at Numab Therapeutics AG, David Urech is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Urech directly — ideal for B2B sales, partnerships, and executive recruiting.
David Urech works in the research industry as CEO at Numab Therapeutics AG. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Urech's profile is kept up-to-date with the latest available information.